Cargando…
Using regulatory genomics data to interpret the function of disease variants and prioritise genes from expression studies
The identification of therapeutic targets is a critical step in the research and developement of new drugs, with several drug discovery programmes failing because of a weak linkage between target and disease. Genome-wide association studies and large-scale gene expression experiments are providing i...
Autor principal: | Ferrero, Enrico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850119/ https://www.ncbi.nlm.nih.gov/pubmed/29568492 http://dx.doi.org/10.12688/f1000research.13577.2 |
Ejemplares similares
-
Consensus clustering and functional interpretation of gene-expression data
por: Swift, Stephen, et al.
Publicado: (2004) -
Connecting genetics and gene expression data for target prioritisation and drug repositioning
por: Ferrero, Enrico, et al.
Publicado: (2018) -
Prioritisation and design of clinical trials
por: Heath, Anna, et al.
Publicado: (2021) -
GAVIN: Gene-Aware Variant INterpretation for medical sequencing
por: van der Velde, K. Joeri, et al.
Publicado: (2017) -
Optimizing genomic medicine in epilepsy through a gene-customized approach to missense variant interpretation
por: Traynelis, Joshua, et al.
Publicado: (2017)